摘要
目的探讨逆行腓动脉穿支筋膜蒂皮瓣和逆行胫后动脉穿支筋膜蒂皮瓣的临床应用效果。方法分析我院2011年2月至2014年3月收治的修复小腿下段和足踝部皮肤软组织缺损患者32例临床资料,依据治疗措施不同进行分组,腓动脉组16例和胫后动脉组16例。结果两组患者疼痛、活动限制、穿鞋限制和功能恢复满意度评分均无明显差异,两组增生性瘢痕、瘙痒、色素沉着的发生率均无明显差异,P>0.05。结论逆行腓动脉穿支筋膜蒂皮瓣与逆行胫后动脉穿支筋膜蒂皮瓣均具有可靠性较高、安全修复范围较大和供区并发症较少的优点。
Objective To approach clinical application result of DPAPF and DPTAPF. Method To analyze 32 cases clinical data of repair period of the leg and foot skin and soft tissue defect patients in our hospital from February 2011 to March 2014, which was to be divided into two group, DPAPF group 16 cases and DPTAPF group 16 cases. Result The pain, activity restrictions, wear shoes restrictions and functional recovery satisfaction score of two groups were no difference, the hyperplastic scar, pruritus, incidence of two groups were no difference, P〉0.05. Conclusion DPAPF and DPTAPF are superior to distally-based posterior tibial artery perforator-plus fasciocutaneous flap in reliability, safe coverage reach and less donor-site morbidities.
出处
《中国医药指南》
2014年第35期47-48,共2页
Guide of China Medicine
